• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在泰国的一家真实记忆诊所中对血浆磷酸化 tau 进行前瞻性评估。

Prospective evaluation of plasma phosphorylated tau in a real-life memory clinic in Thailand.

机构信息

Thai Red Cross Emerging Infectious Diseases Health Science Centre, World Health Organization Collaborating Centre for Research and Training on Viral Zoonoses, King Chulalongkorn Memorial Hospital The Thai Red Cross Society, Bangkok, Thailand.

Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

Alzheimers Dement. 2023 Jun;19(6):2745-2749. doi: 10.1002/alz.13022. Epub 2023 Mar 16.

DOI:10.1002/alz.13022
PMID:36924432
Abstract

INTRODUCTION

Despite the substantial accuracy of plasma p-tau in diagnosing Alzheimer's disease (AD) in research cohorts, data on real-life memory clinic patients are lacking.

METHODS

Memory clinic patients at their early symptomatic stages were prospectively enrolled to undergo routine clinical assessment, plasma p-tau181 quantification (Simoa), amyloid and tau-positron emission tomography (PET). The diagnostic performance of plasma p-tau181, neurocognitive specialists, and regional tau-PET were compared head-to-head using amyloid-PET as the reference standard.

RESULTS

Plasma p-tau181 has the area under the curve (AUC), sensitivity, specificity, and accuracy of 0.84 (95% confidence interval [CI] 0.73-0.94), 0.80 (95% CI 0.64-0.90), 0.75 (95% CI 0.51-0.90), and 0.78 (95% CI 0.65-0.88) for detecting amyloid-PET positivity in early symptomatic patients, respectively. The AUC of clinical diagnosis and tau-PET were 0.70 (95% CI 0.56-0.85) and 0.88 (95% CI 0.79-0.97), respectively.

DISCUSSION

Plasma p-tau181 also performed well in real-life memory clinic settings and its role in clinical practice is supported.

摘要

简介

尽管血浆 p-tau 在研究队列中诊断阿尔茨海默病(AD)的准确性很高,但缺乏关于现实生活中记忆诊所患者的数据。

方法

早期有症状的记忆诊所患者前瞻性入组,接受常规临床评估、血浆 p-tau181 定量(Simoa)、淀粉样蛋白和 tau 正电子发射断层扫描(PET)。使用淀粉样蛋白-PET 作为参考标准,对头对头比较血浆 p-tau181、神经认知专家和区域 tau-PET 的诊断性能。

结果

血浆 p-tau181 的曲线下面积(AUC)、敏感性、特异性和准确性分别为 0.84(95%置信区间 [CI] 0.73-0.94)、0.80(95% CI 0.64-0.90)、0.75(95% CI 0.51-0.90)和 0.78(95% CI 0.65-0.88),用于检测早期有症状患者的淀粉样蛋白-PET 阳性。临床诊断和 tau-PET 的 AUC 分别为 0.70(95% CI 0.56-0.85)和 0.88(95% CI 0.79-0.97)。

讨论

血浆 p-tau181 在现实生活中的记忆诊所环境中也表现良好,支持其在临床实践中的作用。

相似文献

1
Prospective evaluation of plasma phosphorylated tau in a real-life memory clinic in Thailand.在泰国的一家真实记忆诊所中对血浆磷酸化 tau 进行前瞻性评估。
Alzheimers Dement. 2023 Jun;19(6):2745-2749. doi: 10.1002/alz.13022. Epub 2023 Mar 16.
2
Plasma Core Alzheimer's Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline.血浆核心阿尔茨海默病生物标志物可通过正电子发射断层扫描预测认知功能减退中国个体的淀粉样蛋白沉积负担。
ACS Chem Neurosci. 2023 Jan 4;14(1):170-179. doi: 10.1021/acschemneuro.2c00636. Epub 2022 Dec 22.
3
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.血液磷酸化 tau 181 作为阿尔茨海默病的生物标志物:使用来自四个前瞻性队列的数据进行的诊断性能和预测模型研究。
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
4
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.血浆磷酸化tau 种与淀粉样蛋白和 tau 正电子发射断层扫描、神经退行性变、血管病理学以及认知结果的比较。
JAMA Neurol. 2021 Sep 1;78(9):1108-1117. doi: 10.1001/jamaneurol.2021.2293.
5
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.阿尔茨海默病谱中血液磷酸化 tau181 的时间进程。
Brain. 2021 Feb 12;144(1):325-339. doi: 10.1093/brain/awaa399.
6
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status.血浆磷酸化 tau181 作为阿尔茨海默病淀粉样蛋白、tau 和 FDG PET 状态的预测生物标志物。
Transl Psychiatry. 2021 Nov 13;11(1):585. doi: 10.1038/s41398-021-01709-9.
7
Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.用于阿尔茨海默病诊断的 CSF 磷酸化 tau T181 和 T217 生物标志物的临床性能的头对头比较。
Alzheimers Dement. 2021 May;17(5):755-767. doi: 10.1002/alz.12236. Epub 2020 Nov 30.
8
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.阿尔茨海默病神经影像学倡议中血浆磷酸化 tau181 的诊断性能和临床进展预测。
Mol Psychiatry. 2021 Feb;26(2):429-442. doi: 10.1038/s41380-020-00923-z. Epub 2020 Oct 26.
9
Tau in dementia with Lewy bodies.路易体痴呆中的 tau 蛋白。
Aust N Z J Psychiatry. 2024 Feb;58(2):175-182. doi: 10.1177/00048674231177219. Epub 2023 Jun 1.
10
The accuracy and robustness of plasma biomarker models for amyloid PET positivity.血浆生物标志物模型对淀粉样 PET 阳性的准确性和稳健性。
Alzheimers Res Ther. 2022 Feb 7;14(1):26. doi: 10.1186/s13195-021-00942-0.

引用本文的文献

1
[18F]PI-2620 Tau PET signal across the aging and Alzheimer's disease clinical spectrum.[18F]PI - 2620 Tau正电子发射断层扫描信号在衰老及阿尔茨海默病临床谱系中的表现
Imaging Neurosci (Camb). 2024 Oct 24;2. doi: 10.1162/imag_a_00329. eCollection 2024.
2
Effects of a healthy diet based on seed-rich vegetables on the gut microbiota and intrinsic brain activity in perimenopausal women: A pilot study on cognitive improvement.富含种子蔬菜的健康饮食对围绝经期女性肠道微生物群和大脑内在活动的影响:认知改善的一项初步研究
Sci Rep. 2025 May 20;15(1):17444. doi: 10.1038/s41598-025-99406-w.
3
The Bayesian approach for real-world implementation of plasma p-tau217 in tertiary care memory clinics in Thailand.
泰国三级保健记忆诊所中用于实际操作的血浆 p-tau217 的贝叶斯方法。
Alzheimers Dement. 2024 Sep;20(9):6456-6467. doi: 10.1002/alz.14138. Epub 2024 Jul 17.
4
Real-world performance of plasma p-tau181 in a heterogeneous memory clinic cohort.血浆 p-tau181 在异质记忆诊所队列中的真实世界表现。
Ann Clin Transl Neurol. 2024 Aug;11(8):1988-1998. doi: 10.1002/acn3.52116. Epub 2024 Jul 4.
5
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer's Disease.多组学血液生物标志物作为晚发性阿尔茨海默病的动态风险预测指标
Int J Mol Sci. 2024 Jan 19;25(2):1231. doi: 10.3390/ijms25021231.
6
Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers.使用血浆p-tau181和其他基于血液的生物标志物预测淀粉样蛋白PET阳性
Alzheimers Dement (Amst). 2023 Nov 16;15(4):e12502. doi: 10.1002/dad2.12502. eCollection 2023 Oct-Dec.